Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cancer Cell

• Publication date

  2012-08-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ccr.2012.06.005PMID 22897847PMCID PMC3422513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Pediatric Cancer Genome Project

  2012cited by this paper
• The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

  2012influential reference
• Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia.

  2012cited by this paper
• deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data

  2011cited by this paper
• Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

  2011cited by this paper
• ABL1 fusion genes in hematological malignancies: a review

  2011cited by this paper
• CREST maps somatic structural variation in cancer genomes with base-pair resolution

  2011cited by this paper
• Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia

  2011cited by this paper
• Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906

  2011cited by this paper
• Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

  2011cited by this paper
• Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia

  2010cited by this paper
• Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms.

  2010influential reference
• Somatic mutation of EZH2 (Y641) in Follicular and Diffuse Large B-cell Lymphomas of Germinal Center Origin

  2010cited by this paper
• Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

  2010cited by this paper
• LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations

  2010influential reference
• Rearrangement of CRLF 2 is associated with mutation of JAK kinases , alteration of IKZF 1 , Hispanic / Latino ethnicity , and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia *

  2010cited by this paper
• Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.

  2010influential reference
• ALK fusion genes in children with atypical myeloproliferative leukemia

  2010cited by this paper
• Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

  2010cited by this paper
• De novo assembly and analysis of RNA-seq data

  2010cited by this paper
• JAK mutations in high-risk childhood acute lymphoblastic leukemia

  2009influential reference
• Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

  2009cited by this paper
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  2009cited by this paper
• Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

  2009influential reference
• Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

  2009cited by this paper
• Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia

  2009influential reference
• Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

  2009influential reference
• IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

  2009cited by this paper
• Treating childhood acute lymphoblastic leukemia without cranial irradiation.

  2009cited by this paper
• A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin

  2009influential reference
• Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia

  2009influential reference
• A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study.

  2009cited by this paper
• Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).

  2009cited by this paper
• Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

  2009influential reference
• Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates.

  2008cited by this paper
• Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies

  2008influential reference
• Acute lymphoblastic leukaemia.

  2008cited by this paper
• Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore.

  2008cited by this paper
• BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros

  2008cited by this paper
• Fibroblast Growth Factor Receptor and Platelet-Derived Growth Factor Receptor Abnormalities in Eosinophilic Myeloproliferative Disorders

  2008cited by this paper
• A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia.

  2008cited by this paper
• High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• Transcription factors drive B cell development.

  2006cited by this paper
• Arf gene loss enhances oncogenicity and limits imatinib response in mouse models of Bcr-Abl-induced acute lymphoblastic leukemia.

  2006influential reference
• The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.

  2006cited by this paper
• Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

  2005cited by this paper
• A BCR–JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia

  2005cited by this paper
• Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

  2004cited by this paper
• Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.

  2004cited by this paper
• Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments

  2004influential reference
• Nup358/RanBP2 Attaches to the Nuclear Pore Complex via Association with Nup88 and Nup214/CAN and Plays a Supporting Role in CRM1-Mediated Nuclear Protein Export

  2004cited by this paper
• Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.

  2003cited by this paper
• Diagnosis of multiple cancer types by shrunken centroids of gene expression

  2002influential reference
• Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

  2002cited by this paper
• Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

  2002cited by this paper
• Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.

  2000cited by this paper
• Acute lymphoblastic leukaemia.

  1997cited by this paper
• The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways

  1996influential reference
• The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.

  1996influential reference
• The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype.

  1996influential reference
• EBF contains a novel zinc coordination motif and multiple dimerization and transcriptional activation domains.

  1995cited by this paper
• Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

  1994cited by this paper
• Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format

  year unknowncited by this paper

• IRF2BP2::JAK2 Defines a Novel Kinase‐Activating Fusion in Pediatric T‐Cell Acute Lymphoblastic Leukemia

  2026cites this paper
• Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.

  2026cites this paper
• Identification of the Philadelphia-like subgroup in Turkish pediatric patients with acute lymphoblastic leukemia

  2026cites this paper
• From the bench of molecular understanding to the bedside of optimal therapy for BCR::ABL1 and ABL-class acute lymphoblastic leukemia in children and adolescents

  2025cites this paper
• Memory-like Natural Killer Cell and CD19 Antibody–Based Immunotherapy in Combination with Tyrosine Kinase Inhibition Has Antitumor Effects against Ph(-like) Acute Lymphoblastic Leukemia

  2025cites this paper
• A case of T-cell acute lymphoblastic leukemia with co-occurrence of NUP214-ABL1 fusion and tetraploidy: A T-ALL case with NUP214-ABL1 fusion and tetraploidy.

  2025cites this paper
• Paired Tumor/Normal Sequencing Identifies a SEPT9::ABL1 Fusion in a Child With T‐Cell Lymphoblastic Lymphoma

  2025cites this paper
• Selective Sensitivity of Ph-like B-ALL to BRG1 Inhibition Reveals a Novel Targeted Therapy Strategy

  2025cites this paper
• Treatment Approaches for Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

  2025cites this paper
• Enhancer RNAs contribute to genome reprogramming driven by a GATA3 noncoding variant in leukaemia

  2025cites this paper
• Identification of Molecular Subtypes of B-Cell Acute Lymphoblastic Leukemia in Mexican Children by Whole-Transcriptome Analysis

  2025cites this paper
• Mechanistic Insights into Tumorigenesis from Serum Proteins

  2025cites this paper
• Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL

  2025cites this paper
• A limited low-cost method to identify subgroup of B cell-Acute Lymphoblastic Lukemia (B-ALL) with overexpressed CRLF2, JAK2, ABL1 – results from a prospective study

  2025cites this paper
• Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study

  2025cites this paper
• The 5’ fusion partner modulates response to the STAMP inhibitor asciminib in ABL-rearranged ALL

  2025cites this paper
• Acute Lymphoid Leukemia: Is Transplant Indicated for Philadelphia Chromosome Positive ALL?

  2025cites this paper
• PAX Family, Master Regulator in Cancer

  2025cites this paper
• Treatment of EPOR-rearranged acute lymphoblastic leukemia with ruxolitinib: case reports and review of the literature

  2025cites this paper
• Single-cell sequencing revealed the recurrence causes of ETV6::RUNX1 fusion-positive B-ALL in children.

  2025cites this paper
• Survival prediction for Philadelphia chromosome-like acute lymphoblastic leukemia by machine learning analysis: a multicenter cohort study

  2025cites this paper
• PD-1 Expression Promotes Immune Evasion in B-ALL

  2025cites this paper
• Integrated multi-omic analysis reveals novel subtype-specific regulatory interactions in pediatric B-cell acute lymphoblastic leukemia

  2025cites this paper
• Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia.

  2025cites this paper
• Challenging Conventional Diagnostic Methods by Comprehensive Molecular Diagnostics: A Nationwide Prospective Comparison in Children With ALL

  2025cites this paper
• Cryptic to conventional cytogenetics: Philadelphia-like ALL presenting with hypereosinophilia

  2025cites this paper
• A Phase I/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia.

  2025cites this paper
• Integrative genetic and transcriptomic subtyping improves prognosis prediction in B-lineage acute lymphoblastic leukemia.

  2025cites this paper
• Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia

  2024cites this paper
• Optical Genome Mapping for Detection of BCR::ABL1—Another Tool in Our Toolbox

  2024cites this paper
• Philadelphia‐like B‐cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapy

  2024cites this paper
• Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB‐positive acute lymphoblastic leukemia patients: A retrospective multicenter study

  2024cites this paper
• Heterogeneity in chromatin structure drives core regulatory pathways in B-cell Acute Lymphoblastic Leukemia

  2024cites this paper
• Absence of canonical mutations in pediatric essential thrombocytosis: a case series

  2024cites this paper
• TLE3 Is a Novel Fusion Partner of JAK2 in Myeloid/Lymphoid Neoplasm With Eosinophilia Responding to JAK2 Inhibition

  2024cites this paper
• Investigating Genetic and Familial Risks in Childhood ALL: A Longitudinal Virtual Study Using aiHumanoid Simulations of TEL-AML1 Gene Fusion

  2024cites this paper
• SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection

  2024cites this paper
• Overexpression of PTPN21 promotes proliferation of EGF-stimulated acute lymphoblastic leukemia cells via the MAPK signaling pathways

  2024cites this paper
• B Lineage Acute Lymphoblastic Leukemia with concurrent IGH and EPOR rearrangements – An Entity with Dismal Outcome

  2024cites this paper
• New clinical treatment plan for acute lymphoblastic leukemia after whole genome sequencing: An update of the development of new technologies for genome editing

  2024cites this paper
• STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B‐cell acute lymphoblastic leukaemia

  2024cites this paper
• A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens

  2024cites this paper
• IKAROS Family Transcription Factors in Lymphocyte Differentiation and Function.

  2024cites this paper
• 光学显微成像助力肿瘤精准医疗

  2024cites this paper
• A Case of Philadelphia Chromosome-like Acute Lymphoblastic Leukemia with ETV6-PDGFRB Gene Rearrangement: Case Report and Literature Review

  2024cites this paper
• Multifaceted roles of IKZF1 gene, perspectives from bench to bedside

  2024cites this paper
• ERG and c-MYC regulate a critical gene network in BCR::ABL1-driven B cell acute lymphoblastic leukemia

  2024cites this paper
• Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain

  2024cites this paper
• How I Treat Philadelphia Chromosome-like Acute Lymphoblastic Leukemia in Children, Adolescents, and Young Adults.

  2024cites this paper
• Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy

  2024cites this paper
• SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia.

  2024cites this paper
• Early B-Cell Factor 1: An Archetype for a Lineage-Restricted Transcription Factor Linking Development to Disease.

  2024cites this paper
• Role of Transcriptomics in Precision Oncology

  2024cites this paper
• Transcriptome analysis of primary adult B‐cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis

  2024cites this paper
• Modern Classification and Management of Pediatric B-cell Leukemia and Lymphoma.

  2023cites this paper
• Ph-like acute lymphoblastic leukemia in adults: understanding pathogenesis, improving outcomes, and future directions for therapy

  2023influential citation
• Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.

  2023cites this paper
• Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing

  2023influential citation
• The prognostic significance of cytokine receptor-like factor 2 expression and JAK2 mutation in pediatric B-cell acute lymphoblastic leukemia: A prospective cohort study

  2023cites this paper
• Mucin 4 (MUC4) Protein is Expressed in B-Acute Lymphoblastic Leukemia (B-ALL) and is restricted to BCR::ABL1 Positive and BCR::ABL-like Subtypes.

  2023cites this paper
• Acquired uniparental isodisomies involving chromosome 12 in paediatric B‐cell precursor acute lymphoblastic leukaemia: Associations with chromosome 21 gains and SH2B3 mutations

  2023cites this paper
• The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia

  2023cites this paper
• A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia

  2023cites this paper
• IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1‐like B‐acute lymphoblastic leukaemia

  2023cites this paper
• Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child—Diagnostic and Treatment Struggle

  2023cites this paper
• Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia

  2023cites this paper
• Partial Anchored Capture and Long-Read Sequencing (PACLseq) Enable a Stand-alone Diagnostic Method for Ph-like Acute Lymphoblastic Leukemia

  2023cites this paper
• Increased AID Results in Mutations at the CRLF2 Locus Implicated in Latin American ALL Health Disparities

  2023influential citation
• Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia

  2023cites this paper
• Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in ABL Class Rearrangements

  2023cites this paper
• Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression

  2023cites this paper
• Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC

  2023cites this paper
• Transcription factor networks link B-lymphocyte development and malignant transformation in leukemia

  2023cites this paper
• Challenges in clinical interpretation of next-generation sequencing data: Advantages and Pitfalls

  2023cites this paper
• Trends in Childhood Oncology Admissions to ICUs in Australia and New Zealand

  2023cites this paper
• EBF1–JAK2 inhibits the PAX5 function through physical interaction with PAX5 and kinase activity

  2023cites this paper
• SJPedPanel: A pan-cancer gene panel for childhood malignancies

  2023cites this paper
• Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal Aberrations: A Case Report and Literature Review

  2023cites this paper
• BCR::ABL1-like acute lymphoblastic leukaemia: a single institution experience on identification of potentially therapeutic targetable cases

  2023cites this paper
• Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review

  2023cites this paper
• Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia

  2023influential citation
• Molecular Characteristics and Clinical Significance of Acute B-Cell Acute Lymphoblastic Leukemia in Children

  2023cites this paper
• A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects

  2023cites this paper
• Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article

  2023cites this paper
• Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial

  2022cites this paper
• Clinical impact of minimal residual disease and genetic subtypes on the prognosis of childhood acute lymphoblastic leukemia

  2022cites this paper
• Clinical screening for Ph-like ALL and the developing role of TKIs.

  2022cites this paper
• Covert pre-leukaemic clones in healthy co-twins of patients with childhood acute lymphoblastic leukaemia

  2022influential citation
• Hereditary Fusion Genes Are Associated with the Inheritance of Acute Myeloid Leukemia

  2022cites this paper
• RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)

  2022cites this paper
• How T-lymphoblastic leukemia can be classified based on genetics using standard diagnostic techniques enhanced by whole genome sequencing

  2022cites this paper
• Characterization of Philadelphia-like Pre-B Acute Lymphoblastic Leukemia: Experiences in Mexican Pediatric Patients

  2022influential citation
• Sequential approach to improve the molecular classification of childhood acute lymphoblastic leukemia.

  2022cites this paper
• The Pleiotropy of PAX5 Gene Products and Function

  2022cites this paper
• The Hereditary and Epigenetic Fusion Gene Signatures of Multiple Myeloma

  2022cites this paper
• Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion

  2022cites this paper
• Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor acute lymphoblastic leukemia

  2022cites this paper
• Mutant IL7R collaborates with MYC to induce T-cell acute lymphoblastic leukemia

  2022cites this paper
• IL-7: Comprehensive review.

  2022cites this paper
• Nuclear Vav3 is required for polycomb repression complex-1 activity in B-cell lymphoblastic leukemogenesis

  2022cites this paper